Mogroside V Alleviates Renal Injury in Diabetic Mice via Regulation of the TLR4/NF-κB Pathway and Modulation of ECM Remodeling
International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6271
DOI: 10.3390/ijms27146271 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Xiangyu Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guilin Medical University, Guilin 541199, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Triterpenes, NF-kappa B, Signal Transduction. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease, yet effective therapeutic strategies targeting its underlying mechanisms remain limited. Mogroside V (MV), a natural saponin from Siraitia grosvenorii, exhibits anti-inflammatory and antioxidant properties, but its role in DKD is unclear. This study investigated the effects and mechanisms of MV on renal injury in DKD using db/db mice and high-glucose-induced human renal mesangial cells (HRMCs). MV (25–100 mg/kg/d) was orally administered to db/db mice for eight weeks; HRMCs were treated with 0.5–2 μM MV under high-glucose conditions. Renal function, pathological changes, the expression of TLR4/MyD88/NF-κB pathway components, inflammatory cytokines, apoptosis-related factors, and ECM markers were assessed. MV significantly reduced fasting blood glucose, proteinuria, serum creatinine, and urea nitrogen levels, and ameliorated renal pathological injury in db/db mice. Mechanistically, MV downregulated TLR4, MyD88, and p-NF-κBp65 expression, suppressed inflammatory cytokine release (TNF-α, IL-1β, IL-6, MCP-1, IL-18), attenuated apoptosis (increased Bcl-2/Bax ratio, decreased caspase-3), and reduced ECM accumulation (decreased MMP-9, Col IV) both in vivo and in vitro. These findings suggest that MV protects against diabetic kidney disease, potentially by regulating the TLR4/NF-κB signaling pathway and improving extracellular matrix remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Guilin Medical University, Guilin 541199, China.
Zitieren
APA
Guo, X., Shao, H., Zhang, J., Xie, X., Peng, D., & Xu, Q. (2026). Mogroside V Alleviates Renal Injury in Diabetic Mice via Regulation of the TLR4/NF-κB Pathway and Modulation of ECM Remodeling. International Journal of Molecular Sciences, 27(14), 6271. https://doi.org/10.3390/ijms27146271
Vancouver
Guo X, Shao H, Zhang J, Xie X, Peng D, Xu Q. Mogroside V Alleviates Renal Injury in Diabetic Mice via Regulation of the TLR4/NF-κB Pathway and Modulation of ECM Remodeling. International Journal of Molecular Sciences. 2026;27(14):6271. doi:10.3390/ijms27146271
BibTeX
@article{Guo2026,
author = {Guo, Xiangyu and Shao, Hanzhe and Zhang, Jing and Xie, Xiangrong and Peng, Dongcheng and Xu, Qin},
title = {Mogroside V Alleviates Renal Injury in Diabetic Mice via Regulation of the TLR4/NF-κB Pathway and Modulation of ECM Remodeling},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6271},
doi = {10.3390/ijms27146271}
}
EUVIMED